Stockreport

NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF company developing novel treatments for severe neurodegenerative diseases, is pleased to announce its participation in the 2024 International Symposium on ALS/MND, to be [Read more]